Skip to main content

Algae-C Inc. Announces Completion of Acquisition by Rockcliffe Labs Inc.

Written by Customer Service on . Posted in Mergers And Acquisitions.

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) — Algae-C Inc. (“Algae-C”) today announced that it has been acquired by Rockcliffe Labs Inc. (“Rockcliffe Labs”), a Canadian biotechnology venture creation platform. Under the terms of the transaction, all issued and outstanding securities of Algae-C have been exchanged for shares of Rockcliffe Labs. Algae-C is now a subsidiary of Rockcliffe Labs, with former Algae-C shareholders holding a continuing ownership position in the combined enterprise.

Transaction Overview

  • Governance: Algae-C’s operations and management will be integrated into Rockcliffe Labs’ governance and reporting framework.
  • Structure: Rockcliffe Labs acquired control of Algae-C through the purchase of a majority block of securities
  • Consideration: The acquisition was settled in cash, with financial terms undisclosed
  • Ownership: Rockcliffe Labs now holds a controlling equity position, while legacy shareholders retain minority interests.

Strategic Rationale

The acquisition advances Rockcliffe Labs’ strategy of building a diversified biotechnology platform by adding Algae-C’s algae-based molecular discovery and production technology. The combined entity expects to benefit from:

  • Pipeline Expansion: Algae-C’s library of more than 600 identified molecules, including compounds with pharmaceutical, nutraceutical, cosmetic, and industrial applications.
  • Platform Synergies: Integration of Algae-C’s IP portfolio and technical expertise with Rockcliffe Labs’ clinical, regulatory, and commercialization infrastructure.
  • Commercial Pathways: Expanded opportunities for licensing, co-development, and supply agreements supported by scalable biomanufacturing processes.
  • Portfolio Diversification: Risk dispersion across multiple therapeutic and non-therapeutic programs within Rockcliffe Labs’ multi-asset development model.

Integration Plan

Rockcliffe Labs intends to:

  1. Maintain Algae-C’s existing research operations as a specialized unit within the broader platform.
  2. Advance priority algae-derived molecules into validation and pre-clinical development.
  3. Align intellectual property, quality, and regulatory practices with Rockcliffe Labs’ central systems.
  4. Pursue strategic partnerships and licensing arrangements to accelerate commercialization.

Capitalization

Following completion of the acquisition, former Algae-C shareholders collectively hold an ownership interest in Rockcliffe Labs, alongside existing Rockcliffe Labs shareholders and strategic partners, including a Canadian university holding a minority position under a licensing agreement.

About Algae-C

Algae-C Inc. is a Canadian biotechnology company dedicated to algae-based molecular discovery and production. Its proprietary technology enables scalable, sustainable production of high-value compounds with applications in health, wellness, and advanced materials.

About Rockcliffe Labs

Rockcliffe Labs Inc. is a Canadian biotechnology venture creation platform that integrates academic discovery with clinical, regulatory, and capital markets expertise. Through licensing and acquisitions, Rockcliffe Labs builds diversified multi-asset pipelines spanning pharmaceuticals, diagnostics, and bio-based technologies.

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws, including statements regarding the expected benefits of the acquisition, the integration of Algae-C into Rockcliffe Labs, anticipated synergies, future development activities, and commercialization opportunities. Forward-looking information is based on current expectations and assumptions and is subject to risks and uncertainties, including scientific, regulatory, financial, and competitive risks, that may cause actual outcomes to differ materially. Except as required by law, neither Algae-C nor Rockcliffe Labs undertakes any obligation to update or revise forward-looking information.

No Offer or Solicitation

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction. Any securities issued in connection with the acquisition were distributed in reliance on prospectus exemptions available under applicable Canadian securities laws.

Media & Investor Contacts
Algae-C Inc. (Media)
Email: media@algae-c.com
Algae-C Inc. (Investors)
Email: ir@algae-c.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.